Ventricular Tachycardia clinical trials at UCSD
1 research study open to eligible people

  • FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

    open to eligible people ages 18 years and up

    This clinical investigation is intended to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not tolerated or desired.

    San Diego, California and other locations

Last updated: